32
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Measurement of breath hydrogen (H 2) and methane (CH 4) excretion after ingestion of test‐carbohydrates is used for different diagnostic purposes. There is a lack of standardization among centers performing these tests and this, together with recent technical developments and evidence from clinical studies, highlight the need for a European guideline.

          Methods

          This consensus‐based clinical practice guideline defines the clinical indications, performance, and interpretation of H 2‐CH 4‐breath tests in adult and pediatric patients. A balance between scientific evidence and clinical experience was achieved by a Delphi consensus that involved 44 experts from 18 European countries. Eighty eight statements and recommendations were drafted based on a review of the literature. Consensus (≥80% agreement) was reached for 82. Quality of evidence was evaluated using validated criteria.

          Results

          The guideline incorporates new insights into the role of symptom assessment to diagnose carbohydrate (e.g., lactose) intolerances and recommends that breath tests for carbohydrate malabsorption require additional validated concurrent symptom evaluation to establish carbohydrate intolerance. Regarding the use of breath tests for the evaluation of oro‐cecal transit time and suspected small bowel bacterial overgrowth, this guideline highlights confounding factors associated with the interpretation of H 2‐CH 4‐breath tests in these indications and recommends approaches to mitigate these issues.

          Conclusion

          This clinical practice guideline should facilitate pan‐European harmonization of diagnostic approaches to symptoms and disorders, which are very common in specialist and primary care gastroenterology practice, both in adult and pediatric patients. In addition, it identifies areas of future research needs to clarify diagnostic and therapeutic approaches.

          Abstract

          Related collections

          Most cited references246

          • Record: found
          • Abstract: not found
          • Article: not found

          Bacteria, Colonic Fermentation, and Gastrointestinal Health

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus

            Objectives: Breath tests (BTs) are important for the diagnosis of carbohydrate maldigestion syndromes and small intestinal bacterial overgrowth (SIBO). However, standardization is lacking regarding indications for testing, test methodology and interpretation of results. A consensus meeting of experts was convened to develop guidelines for clinicians and research. Methods: Pre-meeting survey questions encompassing five domains; indications, preparation, performance, interpretation of results, and knowledge gaps, were sent to 17 clinician-scientists, and 10 attended a live meeting. Using an evidence-based approach, 28 statements were finalized and voted on anonymously by a working group of specialists. Results: Consensus was reached on 26 statements encompassing all five domains. Consensus doses for lactulose, glucose, fructose and lactose BT were 10, 75, 25 and 25 g, respectively. Glucose and lactulose BTs remain the least invasive alternatives to diagnose SIBO. BT is useful in the diagnosis of carbohydrate maldigestion, methane-associated constipation, and evaluation of bloating/gas but not in the assessment of oro-cecal transit. A rise in hydrogen of ≥20 p.p.m. by 90 min during glucose or lactulose BT for SIBO was considered positive. Methane levels ≥10 p.p.m. was considered methane-positive. SIBO should be excluded prior to BT for carbohydrate malabsorption to avoid false positives. A rise in hydrogen of ≥20 p.p.m. from baseline during BT was considered positive for maldigestion. Conclusions: BT is a useful, inexpensive, simple and safe diagnostic test in the evaluation of common gastroenterology problems. These consensus statements should help to standardize the indications, preparation, performance and interpretation of BT in clinical practice and research.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.

              Breath tests represent a valid and non-invasive diagnostic tool in many gastroenterological conditions. The rationale of hydrogen-breath tests is based on the concept that part of the gas produced by colonic bacterial fermentation diffuses into the blood and is excreted by breath, where it can be quantified easily. There are many differences in the methodology, and the tests are increasingly popular. The Rome Consensus Conference was convened to offer recommendations for clinical practice about the indications and methods of H2-breath testing in gastrointestinal diseases. Experts were selected on the basis of a proven knowledge/expertise in H2-breath testing and divided into Working Groups (methodology; sugar malabsorption; small intestine bacterial overgrowth; oro-coecal transit time and other gas-related syndromes). They performed a systematic review of the literature, and then formulated statements on the basis of the scientific evidence, which were debated and voted by a multidisciplinary Jury. Recommendations were then modified on the basis of the decisions of the Jury by the members of the Expert Group. The final statements, graded according to the level of evidence and strength of recommendation, are presented in this document; they identify the indications for the use of H2-breath testing in the clinical practice and methods to be used for performing the tests.
                Bookmark

                Author and article information

                Contributors
                heinz.hammer@medunigraz.at
                Journal
                United European Gastroenterol J
                United European Gastroenterol J
                10.1002/(ISSN)2050-6414
                UEG2
                United European Gastroenterology Journal
                John Wiley and Sons Inc. (Hoboken )
                2050-6406
                2050-6414
                25 August 2021
                February 2022
                : 10
                : 1 ( doiID: 10.1002/ueg2.v10.1 )
                : 15-40
                Affiliations
                [ 1 ] Division of Gastroenterology and Hepatology Department of Internal Medicine Medical University Graz Austria
                [ 2 ] Centre for Integrative Gastroenterology Digestive Function: Basel Laboratory and Clinic for Motility Disorders and Functional Gastrointestinal Diseases Klinik Arlesheim Arlesheim Switzerland
                [ 3 ] Division of Gastroenterology and Hepatology University Hospital Zurich Zurich Switzerland
                [ 4 ] Department of Internal Medicine Israelitic Hospital Academic Hospital of the University of Hamburg Hamburg Germany
                [ 5 ] Pediatric Department Hospital “F. Del Ponte” University of Insubria Varese Italy
                [ 6 ] Gastroenterology and Endoscopy Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano Italy
                [ 7 ] Department of Gastroenterology and Hepatology University Hospital of Internal Medicine 3 Medical University of Vienna Vienna Austria
                [ 8 ] UOC Medicina Interna e Gastroenterologia Dipartimento di Scienze Mediche e Chirurgiche Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italia
                [ 9 ] Department of Medicine and Ageing Sciences “G. d'Annunzio” University of Chieti‐Pescara Chieti Italy
                [ 10 ] Department of Pediatric Gastroenterology, Hepatology and Nutrition Emma Children's Hospital Amsterdam UMC University of Amsterdam Amsterdam The Netherlands
                [ 11 ] UCL Great Ormond Street Institute of Child Health and Department of Gastroenterology Neurogastroenterology and Motility Great Ormond Street Hospital London UK
                [ 12 ] Department of Gastroenterology Clinica Medicala 2 Cluj‐Napoca Romania
                [ 13 ] Department of Paediatric Gastroenterology, Hepatology and Nutrition KidZ Health Castle UZ Brussel Brussels Belgium
                [ 14 ] Department of Gastroenterology Medical Centre Hungarian Defence Forces Budapest Hungary
                [ 15 ] Clinic of Gastroenterology Tsaritsa Yoanna University Hospital Medical University of Sofia Sofia Bulgaria
                [ 16 ] Gastroenterology, Hepatology and Liver Transplant Queensland Children's Hospital Brisbane Australia
                [ 17 ] Clinic for General Medicine, Gastroenterology, and Infectious Diseases Augustinerinnen Hospital Cologne Germany
                Author notes
                [*] [* ] Correspondence

                Hammer Heinz F, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University, Graz, Austria.

                Email: heinz.hammer@ 123456medunigraz.at

                Author information
                https://orcid.org/0000-0001-8683-4951
                https://orcid.org/0000-0003-4394-5584
                https://orcid.org/0000-0002-5884-1115
                https://orcid.org/0000-0002-2452-1201
                Article
                UEG212133
                10.1002/ueg2.12133
                8830282
                34431620
                cf849119-5c64-4128-8b2b-0212641e9af8
                © 2021 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC. on behalf of United European Gastroenterology.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 08 February 2021
                : 18 June 2021
                Page count
                Figures: 1, Tables: 2, Pages: 26, Words: 21342
                Funding
                Funded by: UEG
                Categories
                Review Article
                Neurogastroenterology
                Custom metadata
                2.0
                February 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.1 mode:remove_FC converted:10.02.2022

                fructose,intolerance,lactose,malabsorption,oro‐cecal transit time,small intestinal bacterial overgrowth

                Comments

                Comment on this article

                scite_

                Similar content45

                Cited by32

                Most referenced authors1,898